SG10201709806VA - Hemagglutinin polypeptides, and reagents and methods relating thereto - Google Patents
Hemagglutinin polypeptides, and reagents and methods relating theretoInfo
- Publication number
- SG10201709806VA SG10201709806VA SG10201709806VA SG10201709806VA SG10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA SG 10201709806V A SG10201709806V A SG 10201709806VA
- Authority
- SG
- Singapore
- Prior art keywords
- reagents
- methods relating
- hemagglutinin polypeptides
- hemagglutinin
- polypeptides
- Prior art date
Links
- 101710154606 Hemagglutinin Proteins 0.000 title 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title 1
- 101710176177 Protein A56 Proteins 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 239000000185 hemagglutinin Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38963910P | 2010-10-04 | 2010-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201709806VA true SG10201709806VA (en) | 2017-12-28 |
Family
ID=44860519
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013024617A SG189236A1 (en) | 2010-10-04 | 2011-10-04 | Hemagglutinin polypeptides, and reagents and methods relating thereto |
| SG10201709806VA SG10201709806VA (en) | 2010-10-04 | 2011-10-04 | Hemagglutinin polypeptides, and reagents and methods relating thereto |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013024617A SG189236A1 (en) | 2010-10-04 | 2011-10-04 | Hemagglutinin polypeptides, and reagents and methods relating thereto |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10226527B2 (en) |
| EP (1) | EP2624864B1 (en) |
| JP (2) | JP6029586B2 (en) |
| CN (1) | CN103328002B (en) |
| AU (1) | AU2011312178B2 (en) |
| BR (1) | BR112013007946B1 (en) |
| CA (1) | CA2813078A1 (en) |
| RU (1) | RU2663718C2 (en) |
| SG (2) | SG189236A1 (en) |
| WO (1) | WO2012047941A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013007946B1 (en) | 2010-10-04 | 2022-07-12 | Massachusetts Institute Of Technology | PHARMACEUTICAL AND IMMUNOGENIC COMPOSITIONS COMPRISING HEMAGGLUTININ POLYPEPTIDES |
| AR083533A1 (en) * | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | PROTEINS OF HEMAGLUTININ 5 (H5) FOR THE TREATMENT AND PREVENTION OF INFLECTIONS OF FLU |
| SG10201708052XA (en) | 2011-09-30 | 2017-11-29 | Medicago Inc | Increasing virus-like particle yield in plants |
| US11390878B2 (en) | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| EP3492101A3 (en) | 2012-05-10 | 2019-10-23 | Massachusetts Institute Of Technology | Agents for influenza neutralization |
| CA2898633C (en) * | 2013-02-07 | 2021-07-13 | Massachusetts Institute Of Technology | Human adaptation of h5 influenza |
| CN105007938A (en) | 2013-03-15 | 2015-10-28 | 宾夕法尼亚大学理事会 | Influenza nucleic acid molecules and vaccines made therefrom |
| EP3626827A1 (en) | 2013-03-28 | 2020-03-25 | Medicago Inc. | Influenza virus-like particle production in plants |
| US11441150B2 (en) | 2014-01-10 | 2022-09-13 | Medicago Inc. | CPMV enhancer elements |
| WO2016100926A1 (en) | 2014-12-19 | 2016-06-23 | Oregon Health & Science University | Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza |
| WO2017083627A1 (en) | 2015-11-13 | 2017-05-18 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| CN113924147A (en) | 2019-03-25 | 2022-01-11 | 威特拉公司 | Compositions and methods for treating and preventing influenza |
| CN110172452B (en) * | 2019-05-21 | 2021-07-06 | 广州医科大学 | Highly pathogenic H7N9 avian influenza virus, vaccine, detection reagent and preparation method of virus and vaccine |
| JP2022038604A (en) | 2020-08-27 | 2022-03-10 | 株式会社Subaru | Vehicle control device for vehicle |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4692411A (en) | 1983-09-06 | 1987-09-08 | Ghose Rabindra N | Separation of specific biological cells by a biochemical filter |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5698390A (en) | 1987-11-18 | 1997-12-16 | Chiron Corporation | Hepatitis C immunoassays |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| FR2638359A1 (en) | 1988-11-03 | 1990-05-04 | Tino Dalto | SYRINGE GUIDE WITH ADJUSTMENT OF DEPTH DEPTH OF NEEDLE IN SKIN |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| SG46445A1 (en) | 1990-01-26 | 1998-02-20 | Immunomedics Inc | Vaccines against cancer and infectious diseases |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (en) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | INJECTION NEEDLE ARRANGEMENT |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| US5500161A (en) | 1993-09-21 | 1996-03-19 | Massachusetts Institute Of Technology And Virus Research Institute | Method for making hydrophobic polymeric microparticles |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| IT1298087B1 (en) | 1998-01-08 | 1999-12-20 | Fiderm S R L | DEVICE FOR CHECKING THE PENETRATION DEPTH OF A NEEDLE, IN PARTICULAR APPLICABLE TO A SYRINGE FOR INJECTIONS |
| WO2002000885A2 (en) | 2000-06-23 | 2002-01-03 | American Cyanamid Company | Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| EP2902484A1 (en) * | 2004-05-25 | 2015-08-05 | MedImmune, LLC | Influenza hemagglutinin and neuraminidase variants |
| WO2006108226A1 (en) | 2005-04-12 | 2006-10-19 | The University Of Queensland | Vaccine delivery system |
| WO2007051036A2 (en) | 2005-10-26 | 2007-05-03 | Protelix, Inc. | Influenza combinatorial antigen vaccine |
| WO2007092792A2 (en) * | 2006-02-02 | 2007-08-16 | Globeimmune, Inc. | Yeast-based vaccine for inducing an immune response |
| WO2007130327A2 (en) | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Influenza virus-like particle (vlp) compositions |
| WO2007130330A2 (en) | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Polyvalent influenza virus-like particle (vlp) compositions |
| EP1998814A4 (en) | 2006-05-11 | 2010-06-16 | Novavax Inc | Novel influenza m2 vaccines |
| US20100143406A1 (en) | 2006-06-30 | 2010-06-10 | Gale Smith | Methods of enhancing protein incorporation into virus like particles |
| AU2007345768B2 (en) | 2006-07-27 | 2013-08-01 | Ligocyte Pharmaceuticals, Inc. | Chimeric influenza virus-like particles |
| EP2044224A4 (en) | 2006-07-27 | 2011-04-13 | Ligocyte Pharmaceuticals Inc | Chimeric virus-like particles |
| CN104278014A (en) * | 2006-08-09 | 2015-01-14 | 米迪缪尼有限公司 | Influenza hemagglutinin and neuraminidase variants |
| CN101501696A (en) * | 2006-08-14 | 2009-08-05 | 麻省理工学院 | Glycan data mining system |
| US20090269342A1 (en) | 2006-08-14 | 2009-10-29 | Massachusetts Institute Of Technology | Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
| US20100061990A1 (en) | 2006-08-14 | 2010-03-11 | Massachusetts Institute Of Technology | Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto |
| AU2007304883B2 (en) | 2006-10-04 | 2013-09-05 | The University Of Queensland | VLP based vaccine delivery system |
| WO2008112017A2 (en) | 2006-10-10 | 2008-09-18 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Healtand Human Services | Avian influenza vaccine |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| US20080233150A1 (en) | 2006-11-16 | 2008-09-25 | Gale Smith | Respiratory syncytial virus-virus like particle (vlps) |
| CA2673994A1 (en) * | 2006-12-29 | 2008-07-24 | Institut Pasteur Of Shanghai | Lentivirus pseudotyped with influenza hemagglutinin and methods of use |
| US8697088B2 (en) | 2007-05-25 | 2014-04-15 | Novavax, Inc. | VLPs derived from cells that do not express a viral matrix or core protein |
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| PT2540312E (en) | 2007-07-19 | 2015-08-31 | Novavax Inc | Avian influenza chimeric vlps |
| EP2237787A4 (en) | 2008-01-03 | 2012-03-21 | Massachusetts Inst Technology | Decoy influenza therapies |
| WO2009089121A2 (en) * | 2008-01-03 | 2009-07-16 | Massachusetts Institute Of Technology | Hemagglutinin polypeptides, and reagents and methods relating thereto |
| MX370690B (en) | 2008-07-18 | 2019-12-19 | Medicago Inc | New influenza virus immunizing epitope. |
| JP5886194B2 (en) | 2009-07-02 | 2016-03-16 | マサチューセッツ インスティテュート オブ テクノロジー | Compositions and methods for diagnosis and / or treatment of influenza infection |
| BR112013007946B1 (en) | 2010-10-04 | 2022-07-12 | Massachusetts Institute Of Technology | PHARMACEUTICAL AND IMMUNOGENIC COMPOSITIONS COMPRISING HEMAGGLUTININ POLYPEPTIDES |
| CA2898633C (en) | 2013-02-07 | 2021-07-13 | Massachusetts Institute Of Technology | Human adaptation of h5 influenza |
-
2011
- 2011-10-04 BR BR112013007946-0A patent/BR112013007946B1/en active IP Right Grant
- 2011-10-04 US US13/253,060 patent/US10226527B2/en active Active
- 2011-10-04 CN CN201180057213.2A patent/CN103328002B/en active Active
- 2011-10-04 WO PCT/US2011/054831 patent/WO2012047941A2/en active Application Filing
- 2011-10-04 JP JP2013531966A patent/JP6029586B2/en active Active
- 2011-10-04 EP EP11774134.8A patent/EP2624864B1/en active Active
- 2011-10-04 SG SG2013024617A patent/SG189236A1/en unknown
- 2011-10-04 SG SG10201709806VA patent/SG10201709806VA/en unknown
- 2011-10-04 CA CA2813078A patent/CA2813078A1/en active Pending
- 2011-10-04 AU AU2011312178A patent/AU2011312178B2/en active Active
- 2011-10-04 RU RU2013114424A patent/RU2663718C2/en active
-
2016
- 2016-02-19 JP JP2016030091A patent/JP6143902B2/en active Active
-
2019
- 2019-01-17 US US16/250,920 patent/US20190142931A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP6143902B2 (en) | 2017-06-07 |
| CN103328002A (en) | 2013-09-25 |
| CA2813078A1 (en) | 2012-04-12 |
| JP2016094483A (en) | 2016-05-26 |
| EP2624864A2 (en) | 2013-08-14 |
| BR112013007946B1 (en) | 2022-07-12 |
| AU2011312178A1 (en) | 2013-05-02 |
| BR112013007946A2 (en) | 2018-04-17 |
| EP2624864B1 (en) | 2017-12-06 |
| AU2011312178B2 (en) | 2016-05-12 |
| JP6029586B2 (en) | 2016-11-24 |
| CN103328002B (en) | 2020-01-14 |
| WO2012047941A3 (en) | 2013-04-11 |
| WO2012047941A2 (en) | 2012-04-12 |
| RU2013114424A (en) | 2014-11-20 |
| US20190142931A1 (en) | 2019-05-16 |
| RU2663718C2 (en) | 2018-08-08 |
| SG189236A1 (en) | 2013-05-31 |
| JP2013543499A (en) | 2013-12-05 |
| US10226527B2 (en) | 2019-03-12 |
| US20120213819A1 (en) | 2012-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201709806VA (en) | Hemagglutinin polypeptides, and reagents and methods relating thereto | |
| EP2713879A4 (en) | Analyte sensor devices, connections, and methods | |
| HK1209761A1 (en) | Polypeptides | |
| GB201115529D0 (en) | Antibodies, uses and methods | |
| GB201115280D0 (en) | Antibodies, uses and methods | |
| EP2606154A4 (en) | Integrated analysis system | |
| RS59462B1 (en) | Polypeptides | |
| EP2818855A4 (en) | Gas sensor element, and gas sensor | |
| EP2609416A4 (en) | Lateral flow assay analysis | |
| EP2672273A4 (en) | Inspection chip, and inspection chip set provided with the inspection chip | |
| EP2632949A4 (en) | Clostridium difficile-specific antibodies and uses thereof | |
| EP2776357A4 (en) | Pivoting arrangement, roof element and elevator | |
| ZA201405554B (en) | Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof | |
| ZA201400766B (en) | Belt-conveying installatio, method for operating the same, and use thereof | |
| EP2594281A4 (en) | Insulin-lipid complex, preparation method therefor, and preparation thereof | |
| EP2718348A4 (en) | Color-producing diagnostic systems, reagents and methods | |
| ZA201406381B (en) | Levoisovalerylspiramycin i,ii,iii,and preparations,preparations methods and uses thereof | |
| IL225990A (en) | Electrophilic reagents for monohalomethylation, their preparation and their uses | |
| HK1198655A1 (en) | High mast2-affinity polypeptides and uses thereof mast2 | |
| EP2657330A4 (en) | Detection tool, and detection system | |
| HK1211042A1 (en) | Inflammation-enabling polypeptides and uses thereof | |
| GB201220902D0 (en) | A novel reagent and method using the same | |
| PL2635838T3 (en) | Element, in particular sealing element | |
| EP2752419A4 (en) | Spirobenzylamine-phosphine, preparation method therefor and use thereof | |
| EP2238146A4 (en) | Hemagglutinin polypeptides, and reagents and methods relating thereto |